Genomic Landscape Alterations in Primary Tumor and Matched Lymph Node Metastasis in Hormone-Naïve Prostate Cancer Patients

Background: Prostate cancer (PCa) is a disease with a wide range of clinical manifestations. Up to the present date, the genetic understanding of patients with favorable or unfavorable prognosis is gaining interest for giving the appropriate tailored treatment. We aimed to investigate genetic change...

Full description

Bibliographic Details
Main Authors: Giorgio Ivan Russo, Paolo Bonacci, Dalida Bivona, Grete Francesca Privitera, Giuseppe Broggi, Rosario Caltabiano, Jessica Vella, Arturo Lo Giudice, Maria Giovanna Asmundo, Sebastiano Cimino, Giuseppe Morgia, Stefania Stefani, Nicolò Musso
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/17/4212
_version_ 1797496123573665792
author Giorgio Ivan Russo
Paolo Bonacci
Dalida Bivona
Grete Francesca Privitera
Giuseppe Broggi
Rosario Caltabiano
Jessica Vella
Arturo Lo Giudice
Maria Giovanna Asmundo
Sebastiano Cimino
Giuseppe Morgia
Stefania Stefani
Nicolò Musso
author_facet Giorgio Ivan Russo
Paolo Bonacci
Dalida Bivona
Grete Francesca Privitera
Giuseppe Broggi
Rosario Caltabiano
Jessica Vella
Arturo Lo Giudice
Maria Giovanna Asmundo
Sebastiano Cimino
Giuseppe Morgia
Stefania Stefani
Nicolò Musso
author_sort Giorgio Ivan Russo
collection DOAJ
description Background: Prostate cancer (PCa) is a disease with a wide range of clinical manifestations. Up to the present date, the genetic understanding of patients with favorable or unfavorable prognosis is gaining interest for giving the appropriate tailored treatment. We aimed to investigate genetic changes associated with lymph node metastasis in a cohort of hormone-naïve Pca patients. Methods: We retrospectively analyzed data from 470 patients who underwent surgery for PCa between 2010 and 2020 at the Department of Urology, University of Catania. Inclusion criteria were patients with lymph node metastasis and patients with PCa with extra capsular extension (pT3) and negative lymph node metastasis. The final cohort consisted of 17 different patients (11 PCa with lymph node metastasis and 6 PCa without lymph node metastasis). Through the cBioPortal online tool, we analyzed gene alterations and their correlations with clinical factors. Results: A total of 688 intronic, synonym and nonsynonym mutations were sequenced. The gene with the most sequenced mutations was ERBB4 (83 mutations, 12% of 688 total), while the ones with the lower percentage of mutations were AKT1, FGFR2 and MLH1 (1 mutation alone, 0.14%). Conclusion: In the present study we found mostly concordance concerning the <i>ERBB4</i> mutation between both primary PCa samples and matched lymph node metastasis, underlining that the identification of alterations in the primary tumor is extremely important for cancer prognosis prediction.
first_indexed 2024-03-10T01:59:10Z
format Article
id doaj.art-bef898b761d34ba098772b82e337f680
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T01:59:10Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-bef898b761d34ba098772b82e337f6802023-11-23T12:51:40ZengMDPI AGCancers2072-66942022-08-011417421210.3390/cancers14174212Genomic Landscape Alterations in Primary Tumor and Matched Lymph Node Metastasis in Hormone-Naïve Prostate Cancer PatientsGiorgio Ivan Russo0Paolo Bonacci1Dalida Bivona2Grete Francesca Privitera3Giuseppe Broggi4Rosario Caltabiano5Jessica Vella6Arturo Lo Giudice7Maria Giovanna Asmundo8Sebastiano Cimino9Giuseppe Morgia10Stefania Stefani11Nicolò Musso12Urology Section, Department of Surgery, University of Catania, 95125 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, ItalyDepartment of Medical and Surgical Sciences and Advanced Technologies “G. F. Ingrassia”, Anatomic Pathology, University of Catania, 95125 Catania, ItalyDepartment of Medical and Surgical Sciences and Advanced Technologies “G. F. Ingrassia”, Anatomic Pathology, University of Catania, 95125 Catania, ItalyUrology Section, Department of Surgery, University of Catania, 95125 Catania, ItalyUrology Section, Department of Surgery, University of Catania, 95125 Catania, ItalyUrology Section, Department of Surgery, University of Catania, 95125 Catania, ItalyUrology Section, Department of Surgery, University of Catania, 95125 Catania, ItalyUrology Section, Department of Surgery, University of Catania, 95125 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, ItalyBackground: Prostate cancer (PCa) is a disease with a wide range of clinical manifestations. Up to the present date, the genetic understanding of patients with favorable or unfavorable prognosis is gaining interest for giving the appropriate tailored treatment. We aimed to investigate genetic changes associated with lymph node metastasis in a cohort of hormone-naïve Pca patients. Methods: We retrospectively analyzed data from 470 patients who underwent surgery for PCa between 2010 and 2020 at the Department of Urology, University of Catania. Inclusion criteria were patients with lymph node metastasis and patients with PCa with extra capsular extension (pT3) and negative lymph node metastasis. The final cohort consisted of 17 different patients (11 PCa with lymph node metastasis and 6 PCa without lymph node metastasis). Through the cBioPortal online tool, we analyzed gene alterations and their correlations with clinical factors. Results: A total of 688 intronic, synonym and nonsynonym mutations were sequenced. The gene with the most sequenced mutations was ERBB4 (83 mutations, 12% of 688 total), while the ones with the lower percentage of mutations were AKT1, FGFR2 and MLH1 (1 mutation alone, 0.14%). Conclusion: In the present study we found mostly concordance concerning the <i>ERBB4</i> mutation between both primary PCa samples and matched lymph node metastasis, underlining that the identification of alterations in the primary tumor is extremely important for cancer prognosis prediction.https://www.mdpi.com/2072-6694/14/17/4212next generation sequencingprognosisoutcomeradical prostatectomyKITABL1
spellingShingle Giorgio Ivan Russo
Paolo Bonacci
Dalida Bivona
Grete Francesca Privitera
Giuseppe Broggi
Rosario Caltabiano
Jessica Vella
Arturo Lo Giudice
Maria Giovanna Asmundo
Sebastiano Cimino
Giuseppe Morgia
Stefania Stefani
Nicolò Musso
Genomic Landscape Alterations in Primary Tumor and Matched Lymph Node Metastasis in Hormone-Naïve Prostate Cancer Patients
Cancers
next generation sequencing
prognosis
outcome
radical prostatectomy
KIT
ABL1
title Genomic Landscape Alterations in Primary Tumor and Matched Lymph Node Metastasis in Hormone-Naïve Prostate Cancer Patients
title_full Genomic Landscape Alterations in Primary Tumor and Matched Lymph Node Metastasis in Hormone-Naïve Prostate Cancer Patients
title_fullStr Genomic Landscape Alterations in Primary Tumor and Matched Lymph Node Metastasis in Hormone-Naïve Prostate Cancer Patients
title_full_unstemmed Genomic Landscape Alterations in Primary Tumor and Matched Lymph Node Metastasis in Hormone-Naïve Prostate Cancer Patients
title_short Genomic Landscape Alterations in Primary Tumor and Matched Lymph Node Metastasis in Hormone-Naïve Prostate Cancer Patients
title_sort genomic landscape alterations in primary tumor and matched lymph node metastasis in hormone naive prostate cancer patients
topic next generation sequencing
prognosis
outcome
radical prostatectomy
KIT
ABL1
url https://www.mdpi.com/2072-6694/14/17/4212
work_keys_str_mv AT giorgioivanrusso genomiclandscapealterationsinprimarytumorandmatchedlymphnodemetastasisinhormonenaiveprostatecancerpatients
AT paolobonacci genomiclandscapealterationsinprimarytumorandmatchedlymphnodemetastasisinhormonenaiveprostatecancerpatients
AT dalidabivona genomiclandscapealterationsinprimarytumorandmatchedlymphnodemetastasisinhormonenaiveprostatecancerpatients
AT gretefrancescaprivitera genomiclandscapealterationsinprimarytumorandmatchedlymphnodemetastasisinhormonenaiveprostatecancerpatients
AT giuseppebroggi genomiclandscapealterationsinprimarytumorandmatchedlymphnodemetastasisinhormonenaiveprostatecancerpatients
AT rosariocaltabiano genomiclandscapealterationsinprimarytumorandmatchedlymphnodemetastasisinhormonenaiveprostatecancerpatients
AT jessicavella genomiclandscapealterationsinprimarytumorandmatchedlymphnodemetastasisinhormonenaiveprostatecancerpatients
AT arturologiudice genomiclandscapealterationsinprimarytumorandmatchedlymphnodemetastasisinhormonenaiveprostatecancerpatients
AT mariagiovannaasmundo genomiclandscapealterationsinprimarytumorandmatchedlymphnodemetastasisinhormonenaiveprostatecancerpatients
AT sebastianocimino genomiclandscapealterationsinprimarytumorandmatchedlymphnodemetastasisinhormonenaiveprostatecancerpatients
AT giuseppemorgia genomiclandscapealterationsinprimarytumorandmatchedlymphnodemetastasisinhormonenaiveprostatecancerpatients
AT stefaniastefani genomiclandscapealterationsinprimarytumorandmatchedlymphnodemetastasisinhormonenaiveprostatecancerpatients
AT nicolomusso genomiclandscapealterationsinprimarytumorandmatchedlymphnodemetastasisinhormonenaiveprostatecancerpatients